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Immunological Determination of Human Fetal Hemoglobin
By HIROMITSÜ TAMACHI
Department of Biochemistry (Director: Prof. Dr. H. Hirai) Hokkaido University School of Medicine,, Sapporo, Japan
(Eingegangen am 1. August 1973)
A new method is described for the immunological determination of human fetal hemoglobin (HbF) using specific antiserum. Whole
blood is pretreated with an alkaline reagent to denature and remove adult hemoglobin (HbA) and other non hemoglobin proteins,
leaving HbF in solution. HbF is then determined by single radial immunodifTusion. The specificity, accuracy and high sensitivity of the
method were found to be satisfactory. The HbF concentration in normal individuals and patients was determined by this method.
Es wird ein neues immunochemisches Verfahren für die Bestimmung von menschlichem fötalen Hämoglobin mittels spezifischen Anti-
serums beschrieben. Das Probenblut wurde mit einem alkalischen Reagenz behandelt, mit dem Erwachsenen-Hämoglobin und andere
Eiweiße außer dem fötalen Hämoglobin denaturiert und von der Lösung ausgeschlossen wurden. Dann wurde der Gehalt des fötalen
Hämoglobins in der Lösung durch die einfache radiale Immunodiffusion bestimmt. Die Spezifität, Genauigkeit und Empfindlichkeit der
Methode war genügend. Fötales Hämoglobin von Gesunden und Kranken wurde mit der vorliegenden Methode bestimmt.
It is well known that HbF increases in some hematologic
diseases, including leukemia (1, 2, 3), hypoplastic
anemia (4, 5), and thalassemia (6, 7). The clinical
significance of this observation and the mechanism of
the change from fetal to adult hemoglobin synthesis is
of interest.
The one minute alkali-denaturation method of SINGER
et al. (8) has been widely used for the determination of
HbF, but there are some problems concerning the
specificity of this determination. Many other methods
for the determination of HbF, such as Chromatographie
(9, 10), spectrographic (11) and amino acid analytical
methods (12) have been reported, but these procedures
are rather complex and their accuracy is not satisfactory,
especially at low concentrations of HbF.
For these reasons, we have attempted to develop a
new method for the determination of HbF based on an
antigen-antibody reaction which is highly specific and
sensitive compared with SINGER'S method. The level of
HbF in some blood specimens from normal individuals
and some patients was determined by this new method.
against non-hemoglobin proteins. Electrophoresis was
carried out according to the method of ROSENBAUM (16).
The non-hemoglobin protein was prepared by the method
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Chromatography of HbF
3 30 cm, Amberlite CG-50
0.04 moi/1 sodium phosphate buffer, pH 6.9 Na+
0.05 mol/l
200 mg of HbF (about 5 ml)
40 ml/h
Experiments and Results
Preparation of Antigen
HbF solution was prepared from cord blood by CHERNOFF'S
method (13), and further purified by Amberlite CG-50 column
chromatography according to the method of ALLEN et al. (14)
to remove non-hemoglobin proteins (15), which would interfere
with the production of specific antiserum against HbF. A partially
purified solution of HbF (5 ml, 40 mg/ml) was applied to a column
(3 30 cm) of Amberlite CG-50 equilibrated with 0.04 mol/1
sodium phosphate buffer, pH 6.9 containing 0.01 mol/1 KCN, and
eluted with the same buffer at a flow rate of 40 ml per hour.
Optical density of fractions was measured at 415 nm
as shown in Figure 1. Under these conditions, fraction I,
II and III were obtained. Non-hemoglobin protein in
these fraction was identified electrophoretically (Fig. 2)
and verified using a precipitin reaction with antisera
HbA C.B. HbF F, II FIU N H P
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Fig. 2
Electrophoretic pattern of various hemoglobin solutions
Supporting media: Cellulose acetate membrane
Buffer: Tris-EDTA-borate buffer pH 9.0
Current time: 0.6 m A/cm 40 min
Staining: Ponceau 3 R
Sample HbA: Hemolysate of normal adult blood
C.B: Hemolysate of cord blood
HbF: HbF purified by CHERNOFF'S method
F>—Fn i : Fractions of HbF on Amberlite CG-50NHP: Non hemoglobin protein
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of WINSLOW et al. (17). All these fractions contained HbF
but the non-hemoglobin protein was found only in
fraction I. Fraction II and III were collected as purified
HbF and used as the antigen.
Production of Antisera
The Antigen solution (HbF: about 20 mg/ml) was mixed with an
equal volume of FREUND'S complete adjuvant and 2 to 2.5 ml of
the mixture containing 20 to 25 mg of HbF was injected sub-
cutaneously into a rabbit's back once a week for 4 to 6 weeks. The
rabbits were periodically bled from marginal ear veins and the
sera were collected for precipitin tests. At 10 to 14 days after the
last injection, the blood was obtained from the Arteria carotis.
The antigen-antibody reaction was studied with the double
diffusion technique in agar according to the method of OUCHTER-
LONY (18). The antigens tested were normal human serum, non-
hemoglobin proteins, HbA0> HbA2, hemolysate of cord blood,
HbF prepared according to CHERNOFF'S method, and the chro-
matographed fractions mentioned previously. HbA0 and HbA2
were prepared according to the method of WINSLOW et al. (17).
The result is shown in Figure 3. The precipitin lines
showed that there were no antigenic differences with
respect to the antiserum used between HbA0 and HbA2,
and also between HbF, its fractions and hemolysate of
cord blood. The precipitin line due to HbA0 (or HbA2)
and that due \t;o HbF, however formed a "spur",
indicating partial antigenic identity of HbA0 and HbF.
This appears to be due to the oc-chain which is common
to both HbA0 and HbF. Therefore, the antibody
against <x-chain in the antiserum was absorbed by
purified HbA2 solution since it was easily obtained free
of HbF. After absorption of antiserum with HbA2, the
antiserum reacted only with HbF and its fractions,
demonstrating that it was specific for HbF as indicated
in Figure 4.
Immunological determination HbF
An HbF solution prepared by means of CHERNOFF'S method as
mentioned previously was serially diluted with saline and used
for standardization. The gels for immunodiffusion were prepared
* * β;
Fig. 3
Precipitin reaction of anti-HbF serum in agar gel
Antiserum: Rabbit antiserum against HbFΝ HP: Non hemoglobin protein
C. B. Cord blood hemolysate
FI-IIJ: Fraction of HbF from Amberlite CG-50
A0: HbA0A2: HbA2
HbF: HbF purified by CHERNOFF'S method
Concentration of proteins: 0.5 mg/ml
Fig. 4
Precipitin reaction of absorbed anti-HbF serum in agar gel
Nomenclature is the same as Fi'g. 3
ab-Antiserum: Anti-HbF serum absorbed with HbA,
in Petri dishes with 0.4 ml of antiserum mixed with 9.6 ml of
1.2% agarose-saline solution. Single radial immunodifrusion was
carried out according to the method of MANCINI et al. (19), and
the squared diameters of precipitin rings were plotted as a function
of antigen concentration.
A linear relation between antigen concentration, and
the squares of the diameters of precipitin rings was
observed as shown in Figure 5. The sensitivity of this
method was 20 mg HbF/ml and the calibration range
was 20 to 600 mg/ml.
Interference with the HbF-anti HbF antibody
reaction by HbA
Though the specific antiserum reacted only with HbF,
it was found that the precipitin rings yielded by hemo-
lysates from normal individuals or patients were so
obscure that the measurement of the diameter of rings
was difficult. In order to understand the reason for
this obscurity of the precipitin ring, various amount of
purified HbA, non-hemoglobin proteins or serum were
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Fig. 5
Calibration curve of HbF by precipitin reaction
Agar gel in the Petri dish contained of 0.4 ml antiserum and 9.6 rnl
1.2% Agarose-saline. Each standard solution of HbF is subjected to
immunodiffusion for 24 to 36 hours
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added to the solution of definite amounts o£ purified
HbF, and these mixtures were subjected to the single
radial immunodiffusion procedure. It was evident that
HbA interfered with the precipitin reaction and the
obscurity of the precipitin rings was observed when
the content of HbA in the mixtures was more than
twice that of HbF. The non-hemoglobin proteins and
serum did not affect the precipitin ring. Why HbA
interferes with the precipitin reaction of HbF is not
clear. Thus it is necessary to remove HbA from the
sample hemolysates prior to immunodiflusion.
Determination of HbF
P retreat went of the blood specimen
Blood was obtained from normal individuals and patients using
either 3.8% sodium citrate or heparin as anticoagulant. Prior to
immunodiffusion, the blood specimens were treated directly with
alkaline reagent according to CHERNOFF'S method (13) to remove
HbA and proteins other than HbF; 2 volumes of whole blood were
mixed with 16 volumes of */i2 mol/1 NaOH solution for various
times at 20°C and then the reaction was stopped with 9 volumes
of saturated (NH^SC^ solution containing 9.5 ml of cone. HC1
per 1.
After a few minutes, the reaction mixtures were centrifuged at
3000 r. p. m. for 10 min to obtain the supernatant as shown in
Figure 6. 4 μ\ of the supernatant was subjected to single radial
immunodiffusion for 24 to 36 h and the amount of HbF (g/J) was
calculated from the calibration curve.
When the specimen was reacted with alkaline reagent
for more than one minute, the precipitin rings were
clear, showing that most of HbA in blood was removed
and its inhibitory effect of formation of precipitin ring
was eliminated. Moreover the longer the reaction time
with alkaline reagent, the smaller the precipitin ring.
This indicated that HbF was also denatured by the
alkaline reagent though its denaturation rate was very
low. When the logarithms of the amounts of HbF
estimated at various intervals were plotted against the
reaction time, straight lines were obtained in all speci-
mens containing various amount of HbF as shown in
Figure 7. This observation indicated that the alkali-
denaturation of HbF was "pseudo" first order reaction.
By extrapolating the straight line to 2ero time, the
quantity of HbF in the specimens can be estimated. The
slope of the lines showed practically the same value
2 volumes whole blood
+
16 volumes Via mol/1 NaOH
Incubation 20°C 2 min
9 volumes saturated (NH4)2SO4 solution
containing cone/ HC1 9.5 ml/I
Centrifugation 3000 r.p.m. 10 min
I Precipitate
Supernatant
I
I
I
Determination
Fig. 6
Alkali-treatment of blood specimen for determination of HbF
I
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Fig. 7
Rate of alkali denaturation of HbF in blood
The bloods which contained various amounts of HbF were prepared by
mixing normal adult blood and cord blood. The procedure for the alkali
denaturation is the same as in Fig. 6 except for the reaction time
k = 3.50 (± 0.14) . 10-3 [min-1] (χ ± s)
regardless of the concentration of HbF in the range from
0.03 to 13.5%. The mean value of the slope was
3.50 (± 0.14) χ 10-2/min (± S. E.)
From this value, the following equation was obtained.
Iogx0 = logxt.+ 3.5 χ 10-2 -1 or x0 = 103-5xl°~2xt-xt
Where x0 is the amount of HbF (g/1) at zero time and
Xt is that at t min.
Practical procedure for determination of HbF
The amount of HbF was determined using the same
procedure described above and calculated by the
following equations.
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Fig. 8
HbF level In some diseases
The dotted lines define the values for normal adults:
5c ± s - 1.53 ± 0.06%
Z. Klin. Chem. Klin. Biochem. / 11. Jahrg. 1973 / Heft 12
504 Tamachi: Immuno logical determination of human fetal hemoglobin
Where, a is the concentration of HbF at zero time, x2
is the concentration of HbF measured after 2 min of
alkali treatment, HbF % is the percent total hemoglobin
measured by the cyanmethemoglobin method. (20), and
13.5 is the reagent dilution factor. The time of alkali
treatment was chosen such that satisfactory amounts of
HbA would be eliminated, that the loss of HbF should
be avoided and also that the reaction time should be as
short as possible: 2 min for the alkali treatment satisfied
these conditions. The reproducibility of the determin-
ation was examined by repeated testing of the same
sample, giving a test error of ± 3%.
HbF levels in some diseases
The percent concentration of HbF in total hemoglobin
was determined using this method for blood samples
from normal individuals and patients with leukemia,
hypoplastic anemia, hyperthyrodism and other diseases.
The results are shown in Figure 8. In some cases, high
values of HbF were observed, but the clinical significance
is not yet clear.
Discussion
For this method, the preparation of monospecific
antiserum against HbF is essential. Hitherto, HbF as
an antigen solution was purified by means of CHERNOFF'S
method, but this method fails to remove all non-
hemoglobin proteins which are quite antigenic com-
pared with HbF, so that the antisera obtained contained
antibodies against non-hemoglobin proteins as well as
HbF. For this reason, HbF was further purified on an
Amberlite CG-50 column to eliminate non-hemoglobin
proteins. The purified HbF preparation, which was
practically free of non-hemoglobin proteins, was used
as an antigen for immunization of rabbits. The anti-
serum thus obtained reacted with HbF and HbA only,
but did not show any reaction with non-hemoglobin
proteins. This indicated that this antiserum contained
only antibodies against the oc and y-chains. The anti-
bodies against the ot-chain were then absorbed by
HbA2. This absorbed antiserum was found to be
highly specific for HbF, and the antibody titer was
satisfactorily high.
The blood specimens were treated directly by the
same alkali-denaturation method as that used for
the preparation of HbF, for the following reasons.
First, HbA interfered with the precipitin reaction
between HbF and its antibodies, so that HbA had
to be removed from the specimens prior to im-
munodiffusion. Second, since the purified HbF used as
the imrriunogen was prepared using the alkali-denatu-
ration procedures, there may be some effect on the
antigenicity of HbF.
Therefore, the blood specimens were also treated by
the same alkali-denaturation procedure on the ex-
pectation that the difference between the antigenic
structure of the immunogen and antigen would be
minimized. Third, instead of hemolysate, whole blood
was directly treated with the alkali reagent, eliminating
the time required for preparation of hemolysate.
For the determination of HbF, SINGER'S method has
been most widely used. Compared with SINGER'S
method, the present method seems to be more specific
for HbF because of the specificity of the antisera
against HbF; moreover in SINGER'S method, it is
possible that some contaminants such as CO-HbA and
other substances which
 % are resistant to the alkali
reagent might contribute to the absorption at 540 nm.
Another advantage of this method is that the time
necessary for preparation of hemolysate in SINGER'S
method is eliminated. The sensitivity of this method is
about 20 times greater than that of SINGER'S method,
since it is possible to determine as little as 20 mg of
HbF per 1. The values of HbF determined by this
method were compared with those by SINGER'S method
with the same samples. The present method gave
results about 10% higher than SINGER'S method. This
difference is greater than expected even taking into
account the fact that the amount of HbF degraded
during l min of the alkali treatment in SINGER?S method
is about 4 percent (21).
A small amount of the alkali-degraded fragment of
HbF may remain in the supernatant. If the absorption at
540 nm of the this fragment were lower than that of
HbF, but its antigenicity were retained, the lower
value by SINGER'S method would be accounted for.
More precise studies are, however, necessary to confirm
this conjecture.
Both this new method and SINGER'S method rely on the
assumption that the denaturation reaction of HbF by
the alkaline reagent is approximately a first order
reaction and the rate of the reaction is constant regardless
of the concentration of HbF. SINGER et al. (22) reported
a different rate of denaturation in some diseases, although
these seemed to be rather exceptional. In 1953, CHERNOFF
developed the immunological determination method of
HbF based on the relationship between the appearerice
time of the precipitin rings and the concentration of
HbF in precipitin tubes. However, when the concen-
tration of HbF in specimens was high, the appearence
time of precipitin rings was so short that the error of
determination became large, and when the concen-
tration of HbF was low, the appearence time was over
100 min (7). For these reasons, the CHERNOFF'S method
might not be satisfactory for routine determination.
The present method utilizing immunodiffusion is more
convenient because the reaction time is short and the
determination of 30 to 40 specimens is possible using
only one gel, though 24 to 36 h are needed for -the
immunodiffusion. KOHN et al. (23) reported recently a
modified single radial immunodiffusion method for the
determination of HbF. In this method, hemolysates,
the concentration of which was adjusted to about
100g/l, were used, as in SINGER'S method, and also
Nigrosin staining of the precipitin rings was necessary
for detection against the HbA background and to
increase the sensitivity. In the present method, HbF
can be determined with satisfactory sensitivity without
resorting to staining or the preparation of an hemolysate.
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